Acutus Medical, Inc. (AFIB) Q4 2022 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you for standing by, and welcome to ACUTUS Medical's fourth quarter and full year 2022 earnings call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 1-1 on your telephone. I would now like to hand the call over to Caroline Corner, Investor Relations. Please go ahead. Thank you, Operator. Welcome to ACUTUS's fourth quarter 2022 earnings call. Joining me on today's call is David Roman, Chief Executive Officer, and Takeo Makai, Chief Financial Officer. This call will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements made on this call that do not relate to matters of historical fact should be considered forward-looking statements. Factors that may cause results to differ from these forward-looking statements are discussed under the forward-looking statement section in the press release attached as an exhibit to ACUTUS's Form 8-K filed with the SEC today, and are also discussed in more detail under the risk factor section in ACUTUS's most recent filings with the SEC, including the risk factors described in ACUTUS's Form 10-K. Any forward-looking statements provided during this call, including projections for future performance, are based on management's expectations as of today. ACUDIS undertakes no obligation to update these statements except as required by applicable law. ACUDIS's press release of fourth quarter 2022 results is available on the ACUDIS website, www.acudismedical.com, under the investor section, and includes additional details about ACUDIS's financial results. The ACUDIS website also has ACUDIS's SEC filings, which you are ...